Addex Therapeutics Stock Analysis

Addex Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.75. Some equities with similar Price to Book (P/B) outperform the market in the long run. Addex Therapeutics recorded a loss per share of 7.37. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 23rd of October 2023. Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system disorders in Switzerland. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland. Addex Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people. For more info on Addex Therapeutics please contact Timothy Dyer at 41 22 884 1555 or go to https://www.addextherapeutics.com.

Addex Therapeutics Investment Alerts

Addex Therapeutics Upcoming and Recent Events

Addex Largest EPS Surprises

View All Earnings Estimates

Addex Therapeutics Environmental, Social, and Governance (ESG) Scores

Addex Stock Institutional Investors

Note, although Addex Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Addex Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.23 M.

Addex Profitablity

The company has Profit Margin (PM) of 17.21 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of (295.51) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $295.51.

Management Efficiency

Addex Therapeutics has return on total asset (ROA) of (0.2248) % which means that it has lost $0.2248 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9072) %, meaning that it created substantial loss on money invested by shareholders. Addex Therapeutics' management efficiency ratios could be used to measure how well Addex Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Addex Therapeutics' Return On Tangible Assets are very stable compared to the past year. As of the 20th of June 2025, Return On Assets is likely to grow to 0.69, while Return On Capital Employed is likely to drop (0.29). At this time, Addex Therapeutics' Non Current Assets Total are very stable compared to the past year. As of the 20th of June 2025, Intangible Assets is likely to grow to about 30.8 M, while Total Assets are likely to drop about 10.1 M.

Technical Drivers

As of the 20th of June, Addex Therapeutics shows the risk adjusted performance of 0.0949, and Mean Deviation of 3.66. Addex Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Addex Therapeutics Price Movement Analysis

Addex Therapeutics Outstanding Bonds

Addex Therapeutics Predictive Daily Indicators

Addex Therapeutics Corporate Filings

Addex Therapeutics Forecast Models

Addex Therapeutics' time-series forecasting models are one of many Addex Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Addex Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Addex Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Addex shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Addex Therapeutics. By using and applying Addex Stock analysis, traders can create a robust methodology for identifying Addex entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Addex analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Addex analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Addex Therapeutics stock analysis indicators help investors evaluate how Addex Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Addex Therapeutics shares will generate the highest return on investment. By understating and applying Addex Therapeutics stock analysis, traders can identify Addex Therapeutics position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.